FDA Investigator Anissa M Vargas
Anissa M Vargas has conducted inspections on 22 sites in 10 countries as of 21 Jan 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
21 Jan 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada,
Argentina,
China,
Germany,
Mexico,
United States of America,
Singapore,
France,
Switzerland,
Netherlands
FDA Investigators that have inspected at least one site in common with Anissa M Vargas:
Alice S Tsao,
Amanda L Fyles,
Ana P Pineda Zavaleta,
Anita Narula, PhD,
Anita R Michael,
Anna Lazar,
Anthony A Charity,
Ariel Cruz Figueroa,
Arnold Seo, PhD,
Arsen Karapetyan,
Ashar P Parikh,
Azza Talaat,
Barbara J Rincon,
Brian D Nicholson,
Camerson E Moore,
Carrie A Hughes,
CDR Thomas R Berry, PPh,
Charisse K Green,
Charles M Edwards,
Chiang Syin, PhD,
Christopher R Czajka,
Concepcion Cruz, Jr,
Crystal Monroy,
Dale A Nyberg,
David M Beltran,
Dell S Moller,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Donna F Campbell,
Douglas C Kovacs,
Dr. Carmelo Rosa,
Edwin Melendez,
Eric L Dong, BS,
Eric M Mueller, PharmD,
Erika V Butler,
Felix Maldonado,
George Lunn, PhD,
German Rivera,
Gregson A Joseph,
Hamet M Toure, PharmD MPH,
Helen B Ricalde,
Heriberto Negron Rivera,
Ivan E Reyes,
Jacqueline S Warner,
James A Liubicich,
James C Maclaughlin,
Joanne M Schlossin,
Jogy George,
John P Mistler,
Jorge L Guadalupe,
José E Meléndez,
Karen E D'orazio,
Katherine Szestypalow,
Kelli F Dobilas,
Kenneth H Williams,
Kent C Faul,
Kevin A Gonzalez,
L Gnnmassimia Massimilla, PharmD,
Larry K Austin,
Lata C Mathew, PhD,
LCDR Michael H Tollon,
Linda K Cline,
Lisa K Capron,
Luella J Rossi,
Luis Mburgos Medero,
Lydia I Rosas Marty,
Madushini Dharmasena, PhD,
Margaret M Annes,
Marianela Aponte Cruz,
Marijo B Kambere, PhD,
Marissa S Steinhagen,
Mark R Mcclain,
Matthew A Spataro,
Matthew J Johnson,
Michael A Charles,
Michael E Maselli,
Michael L Casner,
Michele L Obert,
Miguel A Martinez Perez,
Mindy M Chou,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nancy G Schmidt,
Nataniel Phillips Sylvain, PhD,
Nicholas A Violand,
Nicholas L Hunt,
Nicole E Knowlton,
Parul M Patel,
Patricia H Dlugosz,
Paul E Stein,
Paul Mouris,
Perry T Nichols,
Philip F Istafanos, DMV, MS,
Phillip Angart, PhD,
Rafael Nevarez Nieves,
Raquel Gonzalez Rivera,
Reba A Gates,
Robert D Tollefsen,
Robert J Maffei,
Roger F Zabinski,
Russell K Riley,
S Lori Brown, PhD MPH,
Samina S Khan,
Samuel T Walker,
Sarah E Mcmullen,
Shelby N Turner,
Simone E Pitts,
Sony Mathews,
Sripal R Mada, PhD,
Steven M Weinman,
Tamil Arasu, PhD,
Thomas J Arista,
Tiara Nbrown Crosen,
Tracy K Li,
Valentino Fiorella,
Verlinda A Narcisse,
Vioela J Caze,
Vivin George,
Vlada Matusovsky,
Walden H Lee,
William J Leonard,
Winston R Alejo,
Xing Wang, PhD,
Yumi J Hiramine,
Yvesna C Blaise,
Zachary L Stamm,
Zhongren Wu
Anissa M Vargas's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2020 | EIR | Lonza Bend Inc. - EIR, 2020-01-24 |
| July, 2010 | FDA 483 | Aventis Pharma Manufacturing Pte. Ltd. - Form 483, 2010-07-15 |
| August, 2005 | FDA 483 | Barr Laboratories Inc. - Form 483, 2005-08-25 |
| January, 2020 | FDA 483 | Lonza Bend Inc. - Form 483, 2020-01-24 |
| March, 2005 | FDA 483 | Professional Disposables International, Inc. - Form 483, 2005-03-03 |
| August, 2005 | EIR | Barr Laboratories Inc. - EIR, 2005-08-25 |
| June, 2011 | FDA 483 | Nouryon Chemicals S.A. de C.V. - Form 483, 2011-06-24 |
| October, 2007 | EIR | Barr Laboratories Inc. - EIR, 2007-10-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more